Evidence map›Paper›PMID 25176030›Full record

ArticleProteomics2014

In vitro oxidative footprinting provides insight into apolipoprotein B-100 structure in low-density lipoprotein.

Sourav Chakraborty, Yang Cai, Matthew A Tarr

Abstract read
In one paragraph

Article in Proteomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Rescuing Ischemic Brain Injury by Rewiring Mitochondrial Electron Flow.bioRxiv : the preprint server for biology · 2025
    Article
  2. Review
  3. Article
  4. Receptor-Mediated Drug Delivery Systems Targeting to Glioma.Nanomaterials (Basel, Switzerland) · 2015
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sourav ChakrabortyDepartment of Chemistry, University of New Orleans, New Orleans, LA, USA.
Yang Cai
Matthew A Tarr
University of New Orleans · USChildren's Hospital of New Orleans · US

Funding

Vaccine strategies against pneumocystis in non-human primatesP01HL076100 · NHLBI · LSU HEALTH SCIENCES CENTER · PI SHELLITO, JUDD E · 2004 to 2015
$17.7M
NON CD4 HOST DEFENSE AGAINST P CARINII PNEUMONIAR01HL061271 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 1999 to 2013
$3.6M
NHLBI NIH HHS P01 HL076100NHLBI NIH HHS P01HL076100NHLBI NIH HHS R01 HL061271
6 · The paper itself

Abstract

Low-density lipoprotein (LDL) is a major cholesterol carrier in human blood. Oxidations of apolipoprotein B-100 (apo B-100, LDL protein) could be proatherogenic and play critical roles in early stages of plaque formation in the arterial wall. The structure of apo B-100 is still poorly understood, partially due to its size (550 KDa, 4563 amino acids). To gain an insight into LDL structure, we mapped the regions of apo B-100 in human LDL that were prone to oxidation using peroxynitrite and hypochlorite as probes. In this study, LDL was incubated with various concentrations of peroxynitrite and sodium hypochlorite in bicarbonate buffer. The LDL protein apo B-100 was delipidated, denatured, alkylated, and subjected to tryptic digestion. Tryptic peptides were analyzed employing LC-MS/MS. Database search was performed against the apo B-100 database (SwissProt accession #P04114) using "SEQUEST" algorithm to identify peroxynitrite and hypochlorite-mediated oxidations markers nitrotyrosine, nitrotryptophan, hydroxy-tryptophan, and 3-chlorotyrosine. Several site-specific oxidations were identified in apo B-100 after treatment of intact LDL particles with the oxidants. We hypothesize that these regions could be accessible to oxidant and critical for early events in atherosclerotic plaque deposition.

Indexed as

Amino Acid SequenceApolipoprotein B-100HumansHypochlorous AcidLipoproteins, LDLMolecular Sequence DataOxidantsOxidation-ReductionPeroxynitrous AcidTandem Mass SpectrometryApolipoprotein B-100Hypochlorous AcidLipoproteins, LDLOxidantsPeroxynitrous AcidApo B-100BiomedicineHypochloriteLC-MS/MSox-LDLPeroxynitrite

Identifiers

PMID25176030
PMCPMC4320993
OpenAlexW2044057467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.